James D. Clark - Feb 12, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Stock symbol
CVS
Transactions as of
Feb 12, 2024
Transactions value $
$0
Form type
4
Date filed
2/14/2024, 05:13 PM
Previous filing
Dec 15, 2023
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +2.45K +52.19% $0.00 7.15K Feb 12, 2024 Direct F1
holding CVS Common Stock (Restricted) 8.76K Feb 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 9.05K Feb 12, 2024 Common Stock 9.05K $78.05 Direct F2
holding CVS Stock Option 7.51K Feb 12, 2024 Common Stock 7.51K $62.21 Direct F3
holding CVS Stock Option 24.2K Feb 12, 2024 Common Stock 24.2K $54.19 Direct F4
holding CVS Stock Option 17.2K Feb 12, 2024 Common Stock 17.2K $58.34 Direct F5, F6
holding CVS Stock Option 12.1K Feb 12, 2024 Common Stock 12.1K $74.30 Direct F7
holding CVS Stock Option 6.76K Feb 12, 2024 Common Stock 6.76K $101.09 Direct F8
holding CVS Stock Option 9.65K Feb 12, 2024 Common Stock 9.65K $74.31 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
F2 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F3 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F5 The number of shares subject to the option were calculated using a 30-day average price.
F6 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F8 Option became exercisable in four equal installments, commencing 4/1/2023.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.